CCAMP - InDx 2.0 - NATIONAL DIAGNOSTICS CATAPULT

The C-CAMP Indigenisation of Diagnostics InDx 2.0 program was launched as the National Diagnostics Catapult on 2nd February 2023, to boost India’s preparedness for current & future pandemics, scale up diagnostics for infectious diseases for COVID & beyond.

 

Built on the success of India-wide COVID-19 diagnostics platform, Indigenisation of Diagnostics (C-CAMP InDx) initiative launched in July 2020, C-CAMP InDx 2.0 aims to boost India's preparedness for current and future pandemics and scale up diagnostics space for infectious diseases including but not limited to COVID-19.

 

This programme is supported by the Office of Principal Scientific Adviser to GoI, Rockefeller Foundation (RF), Bill and Melinda Gates Foundation India (BMGF), Foundation for Innovative New Diagnostics (FIND) & Bangalore Life Science Cluster (BLiSC).

 

• Global Leadership: To create a nation-wide diagnostics platform establishing India as a global leader in diagnostics & surveillance capabilities. 
• Robust Diagnostics & Surveillance: To catalyze innovation, development, and commercialization of high-quality, affordable technologies for infectious disease diagnostics and surveillance, for India and beyond.

• Enable and support Indian diagnostic ecosystem to achieve self-sufficiency in manufacturing of molecular diagnostics kits for infectious diseases while also gaining export capabilities. 
• Ensure that Indian companies can build, world class environmental surveillance technologies for sample collection, storage, processing, analysis, and informatics.